Hosted on MSN
NIH stops Johnson & Johnson's blood thinner drug arm in stroke trial after safety review (updated)
Editor’s Note: The story has been updated with comments from J&J The National Institutes of Health (NIH) on Tuesday discontinued the low-dose rivaroxaban arm of its ongoing Phase 3 CAPTIVA stroke ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results